Continuous Glucose Monitoring Program
Funded by the Government of Newfoundland and Labrador (NL) and administered through NL Health Services, the Continuous Glucose Monitor (CGM) program supports medically and financially eligible residents of NL in the purchase of an approved CGM.
Residents eligible for the program include patients who:
- Are permanent residents of Newfoundland and Labrador
- Hold a valid Newfoundland and Labrador Medical Care Plan (MCP) card
- Meet one of the following criteria:
- Have Type 1 diabetes and are under 18 years of age; or
- Have Type 1 diabetes, are between 18 and 24 years of age, and are part of the Newfoundland and Labrador Insulin Pump Program (NLIPP) or are transitioning from the CGM Pilot Project; or
- Have Type 1 diabetes and are pregnant; or
- Have been diagnosed with gestational diabetes during pregnancy
- Meet financial eligibility criteria (where applicable)
How to Participate
To participate, email NLCGMP@nlhealthservices.ca and request an application package.
Continuous Glucose Monitoring Program Expansion Coming this Fall
Starting September 30, 2025, all individuals living with Type 1 diabetes who meet the medical and income-testing criteria will be eligible for the Provincial Continuous Glucose Monitoring Program. Government will share updates of the expansion as they become available.
Modern reassurance for patients, caregivers, and health care providers
Continuous glucose monitoring devices provide blood sugar measurements every few minutes via a small sensor inserted under the skin. The sensor sends information to an attached transmitter and other technology, such as a smart phone. The devices allow the patient, caregiver, or health care provider to monitor blood sugars more frequently and easily than current monitoring devices—such as needle pricking—and can send alerts about high or low blood sugar to prevent hyperglycemic and hypoglycemic events.
Type 1 Diabetes
People with type 1 diabetes aren’t able to produce their own insulin (and can’t regulate their blood sugar) because their body is attacking the pancreas. Type 1 diabetes generally develops in childhood or adolescence, but can also develop in adulthood. People with type 1 need to inject insulin or use an insulin pump to ensure their bodies have the right amount of insulin.
Gestational Diabetes Mellitus
Gestational diabetes mellitus (GDM) is a kind of diabetes that is diagnosed during a pregnancy. It affects how a mother’s body uses sugar and causes high blood sugar, which can impact both the mothers and babies’ health. A diagnosis of GDM is confirmed following a 50g glucose challenge test and/or a 75g oral glucose tolerance test.